A phase IIa study of rhLT&#945;-Da in combination with cisplatin and fluorouracil for patients with metastatic esophageal squamous cell carcinoma or gastric adenocarcinoma.

Wang, Feng-Hua; Wang, Yun; Chen, Zhen-Dong; Chen, Jian-Hua; Qin, Feng-Zhan; Jiang, Wen-Qi; Li, Yu-Hong

A phase IIa study of rhLTα-Da in combination with cisplatin and fluorouracil for patients with metastatic esophageal squamous cell carcinoma or gastric adenocarcinoma.

Wang, Feng-Hua; Wang, Yun; Chen, Zhen-Dong; Chen, Jian-Hua; Qin, Feng-Zhan; Jiang, Wen-Qi; Li, Yu-Hong.

Afiliación

Wang FH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Wang Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Chen ZD; Guangdong Esophageal Cancer Institute, Guangzhou, People's Republic of China.
Chen JH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Qin FZ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Jiang WQ; Guangdong Esophageal Cancer Institute, Guangzhou, People's Republic of China.
Li YH; Department of Medical Oncology, Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.

Med Oncol ; 33(11): 125, 2016 Nov.

Article en En | MEDLINE | ID: mdl-27743200

Asunto(s)

Adenocarcinoma/tratamiento farmacológico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Carcinoma de Células Escamosas/tratamiento farmacológico; Neoplasias Esofágicas/tratamiento farmacológico; Neoplasias Gástricas/tratamiento farmacológico; Adenocarcinoma/patología; Anciano; Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos; Protocolos de Quimioterapia Combinada Antineoplásica/farmacocinética; Carcinoma de Células Escamosas/patología; Cisplatino/administración & dosificación; Cisplatino/efectos adversos; Neoplasias Esofágicas/patología; Carcinoma de Células Escamosas de Esófago; Femenino; Fluorouracilo/administración & dosificación; Fluorouracilo/efectos adversos; Humanos; Masculino; Persona de Mediana Edad; Proteínas Recombinantes/administración & dosificación; Proteínas Recombinantes/efectos adversos; Proteínas Recombinantes/genética; Neoplasias Gástricas/patología; Resultado del Tratamiento; Factor de Necrosis Tumoral alfa/administración & dosificación; Factor de Necrosis Tumoral alfa/genética

Palabras clave

5-fluorouracil; Cisplatin; Esophageal cancer; Gastric cancer; Lymphotoxin-α; Metastases

Buscar en Google

Imprimir

XML

PubMed Links

Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Carcinoma de Células Escamosas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Med Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article

Buscar en Google

Imprimir

XML

PubMed Links